ResearcherHarbin Medical UniversityNo recent work listed
Xinglong Geng
Matched on ORCID iD 0000-0001-7656-6535; OpenAlex author ID A5050795057, A5134022225. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2021: 2 papers · 2022: none · 2023: 3 papers
Papers 5
- Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarcinoma Progression through Extracellular … Co-author DOI 10.1002/advs.202203324↗
- DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216288↗
- circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activation of MMPs in pancreatic cancer. Co-author DOI 10.1186/s12943-023-01847-2↗
- Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.655152↗
- Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. Co-author DOI 10.3389/fonc.2021.630972↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenbo Yang · 5 shared papers, 2021–2023 · strength 0.69
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Zhongjie Zhao · 4 shared papers, 2021–2023 · strength 0.56
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Guanqun Li · 4 shared papers, 2021–2023 · strength 0.54
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Paper Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. DOI 10.3389/fonc.2021.630972↗
- Hongze Chen · 4 shared papers, 2021–2023 · strength 0.54
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Paper Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. DOI 10.3389/fonc.2021.630972↗
- Bei Sun · 4 shared papers, 2021–2023 · strength 0.54
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Paper Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. DOI 10.3389/fonc.2021.630972↗
- Yangyang Zhang · 3 shared papers, 2023 · strength 0.44
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Danxi Liu · 3 shared papers, 2023 · strength 0.44
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Yongwei Wang · 3 shared papers, 2021–2023 · strength 0.41
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Paper Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. DOI 10.3389/fonc.2021.630972↗
- Chundong Cheng · 3 shared papers, 2021–2023 · strength 0.41
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Paper Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. DOI 10.3389/fcell.2021.655152↗
- Jisheng Hu · 3 shared papers, 2021–2023 · strength 0.41
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Paper Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. DOI 10.3389/fcell.2021.655152↗
- Yan Luo · 2 shared papers, 2023 · strength 0.30
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Rui Kong · 2 shared papers, 2023 · strength 0.30
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Le Li · 2 shared papers, 2023 · strength 0.28
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Paper Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarc… DOI 10.1002/advs.202203324↗
- Le Li · 2 shared papers, 2021–2023 · strength 0.28
- Tao Zhang · 2 shared papers, 2021–2023 · strength 0.27
- Liwei Liu · 1 shared paper, 2023 · strength 0.15
- Hongze Chen · 1 shared paper, 2023 · strength 0.15
- Bei Sun · 1 shared paper, 2023 · strength 0.15
- Zengfu Song · 1 shared paper, 2023 · strength 0.14
- Shangha Pan · 1 shared paper, 2023 · strength 0.14
- Xuewei Bai · 1 shared paper, 2023 · strength 0.14
- Gang Wang · 1 shared paper, 2023 · strength 0.14
- Yang Zhang · 1 shared paper, 2021 · strength 0.13
- Le Li · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.